Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Hematology

The Diagnostic Journey: Confirming Fanconi Anemia

At a Glance

Fanconi anemia is confirmed with specialized chromosome breakage testing using DEB or MMC and genetic testing. A normal blood test does not always rule it out because somatic mosaicism can mask the condition; skin fibroblast testing may be needed.

The path to a Fanconi anemia (FA) diagnosis is rarely a straight line. Because FA is so rare and its symptoms often overlap with other conditions, getting to the right answer requires a specific sequence of “gold standard” tests interpreted by a specialized laboratory. Understanding these tests—and why a single negative result may not be the final answer—is essential for ensuring your child receives the safest possible care.

Functional Testing: Chromosome Breakage Assays

A central tool in evaluating suspected FA is the chromosome breakage assay, typically using chemicals called diepoxybutane (DEB) or mitomycin C (MMC) [1][2].

This test works by putting your child’s cells “under stress” to see how they react:

  • The Stress Test: In a laboratory, a technician takes a sample of your child’s blood and exposes the white blood cells (lymphocytes) to DEB or MMC [3]. These chemicals are crosslinking agents, which means they “glue” the strands of DNA together.
  • The Repair Check: A healthy cell has a functional FA/BRCA pathway that acts like a repair crew, ungluing the DNA so the cell can continue to grow. In a child with FA, this repair crew is missing or broken.
  • The Result: When FA cells are exposed to these chemicals, the DNA strands break and form unusual, star-shaped patterns called radial figures [4]. Seeing these breaks and radial figures strongly supports the diagnosis [2]. However, results should be reviewed by an FA-experienced laboratory and followed up with genetic testing, as no single result should be interpreted in isolation.

The Challenge of Somatic Mosaicism

In some children, a blood test might come back normal or “borderline” even when they actually have Fanconi anemia. This happens because of a phenomenon called somatic mosaicism (or “revertant” mosaicism) [5].

Think of this as a “self-correction” by the body. Occasionally, one of the child’s blood-forming cells spontaneously “fixes” its own genetic mutation [6]. Because these “fixed” cells are healthier and stronger than FA cells, they can eventually take over the blood system.

  • The False Negative: If a blood test is performed on these self-corrected cells, it will look normal, hiding the fact that every other cell in the child’s body still has FA [7].
  • The Solution: If a doctor still suspects FA despite a normal blood test, they often perform the breakage assay on skin fibroblasts (a small skin biopsy) [8]. Unlike blood cells, skin cells rarely “self-correct,” providing a clearer picture [9].

Genetic Testing: Finding the “Which” and “Why”

While a positive breakage test strongly suggests FA, the next step is genetic sequencing (often using Next-Generation Sequencing or NGS) to identify which of the 22 FANC genes is mutated [10].

Identifying the specific gene is crucial for several reasons:

  1. Confirmation: It provides definitive proof of the diagnosis and identifies the exact genetic “address” of the problem [11]. Note that finding a “Variant of Uncertain Significance” (VUS) does not confirm the diagnosis on its own.
  2. Family Testing: It allows doctors to test parents and siblings to see if they are carriers or if other children in the family are also affected [12].
  3. Detecting “Missing” Pieces: Standard sequencing sometimes misses large chunks of missing DNA. Doctors should also perform copy number analysis to look for these larger deletions [13].

A Dangerous Misdiagnosis: Idiopathic Aplastic Anemia

One of the most critical reasons for precise testing is to avoid a misdiagnosis of idiopathic aplastic anemia (iAA). “Idiopathic” means “of unknown cause.” Some children with FA who do not have physical birth defects are initially suspected to have iAA [14].

Why this misdiagnosis is dangerous:
The standard treatments for acquired iAA often involve conditioning regimens tailored to normal cells. However, because FA cells are hypersensitive to DNA damage, standard conditioning doses can cause life-threatening toxicity or poor outcomes in a child with FA [15][16]. A child with FA requires an FA-experienced transplant center to verify the diagnosis and tailor a reduced-toxicity conditioning regimen designed to protect their fragile cells while allowing new donor cells to engraft [17][18].

Differentiating FA from Other Syndromes

FA is one of several inherited bone marrow failure syndromes (IBMFS). While they all cause low blood counts, they have different causes and require different treatments [19]:

  • Dyskeratosis Congenita: Affects the “caps” on the ends of chromosomes (telomeres). Doctors differentiate this by measuring telomere length [20].
  • Diamond-Blackfan Anemia: Primarily affects red blood cell production rather than all blood cell types [21].
  • Shwachman-Diamond Syndrome: Often involves issues with the pancreas and digestion in addition to low blood counts [21].

Because these conditions can look similar, specialized genetic panels are used to look at dozens of genes simultaneously to ensure the diagnosis is correct [22].

Common questions in this guide

What test is used to confirm Fanconi anemia?
A chromosome breakage assay exposes blood cells to DEB or MMC and looks for DNA breaks and radial figures. A positive result strongly supports Fanconi anemia, but an FA-experienced laboratory should interpret it alongside genetic testing rather than relying on one result alone.
Can a normal blood test rule out Fanconi anemia?
No. Somatic mosaicism can cause corrected blood-forming cells to take over, making blood breakage testing look normal or borderline even though other cells still have Fanconi anemia. If suspicion remains, doctors may test skin fibroblasts from a small biopsy because these cells are less likely to self-correct.
What does genetic testing look for in Fanconi anemia?
Sequencing examines the 22 FANC genes, while copy number analysis can detect larger missing sections of DNA that standard sequencing may miss. A variant of uncertain significance, meaning a genetic change whose effect is not yet clear, does not confirm Fanconi anemia by itself. Genetic results can also guide testing for parents and siblings.
Why must Fanconi anemia be confirmed before a bone marrow transplant?
Cells in Fanconi anemia are unusually sensitive to DNA damage. Standard conditioning chemotherapy or radiation used for other forms of aplastic anemia can cause severe toxicity or poor outcomes, so an FA-experienced transplant center should use a reduced-toxicity plan when appropriate.
How is Fanconi anemia distinguished from other inherited bone marrow failure syndromes?
Doctors combine the breakage assay, genetic testing, and clinical information. Telomere length testing can help assess dyskeratosis congenita, while pancreatic and digestive problems or mainly low red-cell production can point toward Shwachman-Diamond syndrome or Diamond-Blackfan anemia. Specialized gene panels may examine many genes at once.
Should family members be tested after a Fanconi anemia diagnosis?
Genetic counseling can help determine whether parents or siblings should be tested for carrier status or Fanconi anemia. The specific FANC gene change can guide family testing and discussions about risks for other or future children.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Has my child had the DEB or MMC chromosome breakage test, and were the results clearly positive, or could they indicate somatic mosaicism?
  2. 2.If the blood test was negative or borderline, should we proceed with a skin biopsy (fibroblast testing) to definitively rule out Fanconi anemia?
  3. 3.Does the genetic testing include 'copy number analysis' to look for large deletions that standard sequencing might miss?
  4. 4.How does my child's specific FANC gene mutation affect their expected disease course and our family's screening needs?
  5. 5.If a transplant is needed, can you confirm that the conditioning regimen is specifically designed for Fanconi anemia and avoids standard high-dose chemotherapy or radiation?
  6. 6.How have we ruled out other similar conditions, like Dyskeratosis Congenita or Diamond-Blackfan Anemia?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    When to consider inherited marrow failure syndromes in adults.

    Gutierrez-Rodrigues F, Patel BA, Groarke EM

    Hematology. American Society of Hematology. Education Program 2023; (2023(1)):548-555 doi:10.1182/hematology.2023000488.

    PMID: 38066926
  2. 2

    Diagnosis of Fanconi anemia by diepoxybutane analysis.

    Auerbach AD

    Current protocols in human genetics 2015; (85()):8.7.1-8.7.17 doi:10.1002/0471142905.hg0807s85.

    PMID: 25827349
  3. 3

    Fanconi anemia-associated chromosomal radial formation is dependent on POLθ-mediated alternative end joining.

    Rogers CB, Kram RE, Lin K, et al.

    Cell reports 2023; (42(5)):112428 doi:10.1016/j.celrep.2023.112428.

    PMID: 37086407
  4. 4

    Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway.

    Lopez-Martinez D, Liang CC, Cohn MA

    Cellular and molecular life sciences : CMLS 2016; (73(16)):3097-114 doi:10.1007/s00018-016-2218-x.

    PMID: 27094386
  5. 5

    Somatic mosaicism in patients with Fanconi anaemia: Proposal of alternative tissue for inconclusive diagnoses.

    Oliveira Pereira C, Pillonetto DV, Borgonovo T, et al.

    International journal of laboratory hematology 2022; (44(5)):900-906 doi:10.1111/ijlh.13874.

    PMID: 35644995
  6. 6

    Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.

    Nicoletti E, Rao G, Bueren JA, et al.

    Annals of hematology 2020; (99(5)):913-924 doi:10.1007/s00277-020-03954-2.

    PMID: 32065290
  7. 7

    Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients.

    Ramírez MJ, Pujol R, Trujillo-Quintero JP, et al.

    American journal of hematology 2021; (96(8)):989-999 doi:10.1002/ajh.26234.

    PMID: 33984160
  8. 8

    Cytogenetic findings in Polish patients with suspected Fanconi anemia.

    Repczyńska A, Jułga K, Lorenc A, et al.

    Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2024; (33(4)):361-368 doi:10.17219/acem/168825.

    PMID: 37540155
  9. 9

    Somatic mosaicism of an intragenic FANCB duplication in both fibroblast and peripheral blood cells observed in a Fanconi anemia patient leads to milder phenotype.

    Asur RS, Kimble DC, Lach FP, et al.

    Molecular genetics & genomic medicine 2018; (6(1)):77-91 doi:10.1002/mgg3.350.

    PMID: 29193904
  10. 10

    Next-generation sequencing reveals novel variants and large deletion in FANCA gene in Polish family with Fanconi anemia.

    Repczynska A, Julga K, Skalska-Sadowska J, et al.

    Orphanet journal of rare diseases 2022; (17(1)):282 doi:10.1186/s13023-022-02424-4.

    PMID: 35854323
  11. 11

    Profiling Fanconi Anemia Gene Mutations among Iranian Patients.

    Esmail Nia G, Fadaee M, Royer R, et al.

    Archives of Iranian medicine 2016; (19(4)):236-40 doi:0161904/AIM.003.

    PMID: 27041517
  12. 12

    Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia.

    Savage SA, Walsh MF

    Hematology/oncology clinics of North America 2018; (32(4)):657-668 doi:10.1016/j.hoc.2018.04.002.

    PMID: 30047418
  13. 13

    Comprehensive laboratory diagnosis of Fanconi anaemia: comparison of cellular and molecular analysis.

    Joshi G, Arthur NBJ, Geetha TS, et al.

    Journal of medical genetics 2023; (60(8)):801-809 doi:10.1136/jmg-2022-108714.

    PMID: 36894310
  14. 14

    Genetic insights and diagnostic challenges in inherited bone marrow failure syndromes: a comprehensive study from a low middle-income country.

    Bukhari SI, Akbar F, Kirmani S, et al.

    Expert review of hematology 2026; (19(3)):345-355 doi:10.1080/17474086.2025.2610748.

    PMID: 41445363
  15. 15

    Hematopoietic Stem Cell Transplant in Adult Patients with Fanconi Anemia: A Review.

    Rockwell B, Ramamurthy P, Verceles JA, et al.

    Diseases (Basel, Switzerland) 2025; (13(7)) doi:10.3390/diseases13070195.

    PMID: 40709985
  16. 16

    Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.

    Anur P, Friedman DN, Sklar C, et al.

    Bone marrow transplantation 2016; (51(7)):938-44 doi:10.1038/bmt.2016.32.

    PMID: 26999465
  17. 17

    Four decades of stem cell transplantation for Fanconi anaemia in the Netherlands.

    Smetsers SE, Smiers FJ, Bresters D, et al.

    British journal of haematology 2016; (174(6)):952-61 doi:10.1111/bjh.14165.

    PMID: 27470218
  18. 18

    Results of Allogenic Hematopoietic Stem Cell Transplantation in Fanconi Anemia Caused by Bone Marrow Failure: Single-Regimen, Single-Center Experience of 14 Years.

    Tuysuz G, Guler E, Ozel D, Kupesiz A

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019; (25(10)):2017-2023 doi:10.1016/j.bbmt.2019.05.039.

    PMID: 31199982
  19. 19

    Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes.

    Ghemlas I, Li H, Zlateska B, et al.

    Journal of medical genetics 2015; (52(9)):575-84 doi:10.1136/jmedgenet-2015-103270.

    PMID: 26136524
  20. 20

    Mechanisms of somatic transformation in inherited bone marrow failure syndromes.

    Choijilsuren HB, Park Y, Jung M

    Hematology. American Society of Hematology. Education Program 2021; (2021(1)):390-398 doi:10.1182/hematology.2021000271.

    PMID: 34889377
  21. 21

    Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia.

    Savage SA, Dufour C

    Seminars in hematology 2017; (54(2)):105-114 doi:10.1053/j.seminhematol.2017.04.004.

    PMID: 28637614
  22. 22

    Genetics and genomics of bone marrow failure syndrome.

    Kim HY, Kim HJ, Kim SH

    Blood research 2022; (57(S1)):86-92 doi:10.5045/br.2022.2022056.

    PMID: 35483932

This page explains Fanconi anemia testing for informational purposes only and does not constitute medical advice. A hematologist and an FA-experienced laboratory or transplant center should interpret your child's results and plan care.

Get notified when new evidence is published on Fanconi anemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.